Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers.

PLoS Genet
Authors
Keywords
Abstract

We previously used a single nucleotide polymorphism (SNP) in the CHRNA5-A3-B4 gene cluster associated with heaviness of smoking within smokers to confirm the causal effect of smoking in reducing body mass index (BMI) in a Mendelian randomisation analysis. While seeking to extend these findings in a larger sample we found that this SNP is associated with 0.74% lower body mass index (BMI) per minor allele in current smokers (95% CI -0.97 to -0.51, P = 2.00 × 10(-10)), but also unexpectedly found that it was associated with 0.35% higher BMI in never smokers (95% CI +0.18 to +0.52, P = 6.38 × 10(-5)). An interaction test confirmed that these estimates differed from each other (P = 4.95 × 10(-13)). This difference in effects suggests the variant influences BMI both via pathways unrelated to smoking, and via the weight-reducing effects of smoking. It would therefore be essentially undetectable in an unstratified genome-wide association study of BMI, given the opposite association with BMI in never and current smokers. This demonstrates that novel associations may be obscured by hidden population sub-structure. Stratification on well-characterized environmental factors known to impact on health outcomes may therefore reveal novel genetic associations.

Year of Publication
2014
Journal
PLoS Genet
Volume
10
Issue
12
Pages
e1004799
Date Published
2014 Dec
ISSN
1553-7404
URL
DOI
10.1371/journal.pgen.1004799
PubMed ID
25474695
PubMed Central ID
PMC4256159
Links
Grant list
PG/13/66/30442 / British Heart Foundation / United Kingdom
MC_UU_12013/6 / Medical Research Council / United Kingdom
MC_UU_12019/1 / Medical Research Council / United Kingdom
MR/K023195/1 / Medical Research Council / United Kingdom
102215 / Wellcome Trust / United Kingdom
MC_PC_15018 / Medical Research Council / United Kingdom
MC_UU_12013/1 / Medical Research Council / United Kingdom
MR/J01351X/1 / Medical Research Council / United Kingdom
CZD/16/6/4 / Chief Scientist Office / United Kingdom
UL1 TR001425 / TR / NCATS NIH HHS / United States
MR/K013351/1 / Medical Research Council / United Kingdom
R01 DA018673 / DA / NIDA NIH HHS / United States
RG/13/16/30528 / British Heart Foundation / United Kingdom